126 related articles for article (PubMed ID: 11438554)
1. Gene therapy for antiangiogenesis.
Kleinman HK; Liau G
J Natl Cancer Inst; 2001 Jul; 93(13):965-7. PubMed ID: 11438554
[No Abstract] [Full Text] [Related]
2. Researchers target tumour blood vessels with antiangiogenic gene therapy.
Frankish H
Lancet; 2002 Jun; 359(9325):2256. PubMed ID: 12103296
[No Abstract] [Full Text] [Related]
3. Cancer gene therapy targeting angiogenesis: an updated review.
Liu CC; Shen Z; Kung HF; Lin MC
World J Gastroenterol; 2006 Nov; 12(43):6941-8. PubMed ID: 17109514
[TBL] [Abstract][Full Text] [Related]
4. Cell-based delivery systems for antiangiogenic therapy.
Machluf M; Carroll RS
Biotechnol Genet Eng Rev; 2003; 20():183-95. PubMed ID: 14997852
[No Abstract] [Full Text] [Related]
5. Fishing for a cure. Does the tiny zebrafish hold a key to stopping tumor growth?
Kiser K
Minn Med; 2005 Apr; 88(4):8-9. PubMed ID: 15940882
[No Abstract] [Full Text] [Related]
6. Modeling antiangiogenesis gene therapy.
Tsai JH; Lee WM
Cancer Biol Ther; 2002; 1(5):554-5. PubMed ID: 12496488
[No Abstract] [Full Text] [Related]
7. Antiangiogenesis: new frontiers in therapeutic development.
LaMontagne KR
Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
[No Abstract] [Full Text] [Related]
8. Targeting tumor angiogenesis with gene therapy.
Chen QR; Zhang L; Gasper W; Mixson AJ
Mol Genet Metab; 2001; 74(1-2):120-7. PubMed ID: 11592809
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation.
Kubota T; Taiyoh H; Matsumura A; Murayama Y; Ichikawa D; Okamoto K; Fujiwara H; Ikoma H; Nakanishi M; Kikuchi S; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Suzuki Y; Matsumoto K; Nakamura T; Otsuji E
Int J Cancer; 2009 Dec; 125(12):2879-86. PubMed ID: 19588506
[TBL] [Abstract][Full Text] [Related]
10. Future prospects and challenges of antiangiogenic cancer gene therapy.
Samaranayake H; Määttä AM; Pikkarainen J; Ylä-Herttuala S
Hum Gene Ther; 2010 Apr; 21(4):381-96. PubMed ID: 20163246
[TBL] [Abstract][Full Text] [Related]
11. Is angiogenesis an organizing principle in biology and medicine?
Folkman J
J Pediatr Surg; 2007 Jan; 42(1):1-11. PubMed ID: 17208533
[No Abstract] [Full Text] [Related]
12. Gene therapy strategies for tumor antiangiogenesis.
Kong HL; Crystal RG
J Natl Cancer Inst; 1998 Feb; 90(4):273-86. PubMed ID: 9486813
[TBL] [Abstract][Full Text] [Related]
13. Cancer research. Obstacle for promising cancer therapy.
Marx J
Science; 2002 Feb; 295(5559):1444. PubMed ID: 11859164
[No Abstract] [Full Text] [Related]
14. Molecular predictors of response to antiangiogenesis therapies.
Gerger A; LaBonte M; Lenz HJ
Cancer J; 2011; 17(2):134-41. PubMed ID: 21427557
[TBL] [Abstract][Full Text] [Related]
15. Vascular normalization: study examines how antiangiogenesis therapies work.
Webb T
J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
[No Abstract] [Full Text] [Related]
16. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
17. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenics meet nanotechnology.
Ruoslahti E
Cancer Cell; 2002 Aug; 2(2):97-8. PubMed ID: 12204528
[TBL] [Abstract][Full Text] [Related]
19. Turning on the angiogenic microswitch.
Eilken HM; Adams RH
Nat Med; 2010 Aug; 16(8):853-4. PubMed ID: 20689545
[No Abstract] [Full Text] [Related]
20. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
